The combination of high-fat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammation

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Teixeira, Lílian G ^a   Leonel, Alda J ^a   Aguilar, Edenil C ^a   Batista, Nathália V ^a   Alves, Andréa C ^a   Coimbra, Candido C ^a   Ferreira, Adaliene V M ^a   De Faria, Ana Maria C ^a   Cara, Denise C ^a   Alvarez Leite, Jacqueline I ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

high fat diet induced obesity and inflammation; obesity; ulcerative colitis

Indexed keywords

CELL ADHESION MOLECULE; DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR; ADIPOCYTOKINE; CHEMOKINE; CYTOKINE; LEPTIN RECEPTOR; LEUKOCYTE ANTIGEN; TOLL LIKE RECEPTOR 4;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; INFLAMMATION; INFLAMMATORY INFILTRATE; LEUKOCYTE MIGRATION; LIPID BLOOD LEVEL; LIPID DIET; LYMPHOCYTE; MACROPHAGE; MALE; NEUTROPHIL; NONHUMAN; OBESITY; PROTEIN EXPRESSION; ULCERATIVE COLITIS; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; COLON; EPIDIDYMIS; GENE EXPRESSION; GENETICS; METABOLISM; MICROVASCULATURE; MOUSE; PATHOLOGY; T LYMPHOCYTE; VASCULARIZATION;

ANIMALIA; MUS;

ADIPOKINES; ADIPOSE TISSUE; ADIPOSITY; ANIMALS; ANTIGENS, CD; CHEMOKINES; COLITIS, ULCERATIVE; COLON; CYTOKINES; DEXTRAN SULFATE; DIET, HIGH-FAT; EPIDIDYMIS; GENE EXPRESSION; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICROVESSELS; OBESITY; RECEPTORS, LEPTIN; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 4;

EID: 80755159366     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-204     Document Type: Article

References (53)

1. Advances in the pathogenesis and treatment of IBD. Braus NA, Elliott DE, Clin Immunol 2009 132 1 9 10.1016/j.clim.2009.02.006 19321388
2. Management of ulcerative colitis in the morbidly obese patient: is bariatric surgery indicated? Lascano CA, Soto F, Carrodeguas L, et al. Obes Surg 2006 16 783 786 10.1381/096089206777346718 16756744 (Pubitemid 43874839)
3. The epidemiology and the pathogenesis of inflammatory bowel disease. Karlinger K, Gyorke T, Mako E, Mester A, Tarjan Z, Eur J Radiol 2000 35 154 167 10.1016/S0720-048X(00)00238-2 11000558
4. Adipose tissue, inflammation, and cardiovascular disease. Berg AH, Scherer PE, Circ Res 2005 96 939 949 10.1161/01.RES.0000163635.62927.34 15890981 (Pubitemid 40712793)
5. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Trayhurn P, Wood IS, Br J Nutr 2004 92 347 355 10.1079/BJN20041213 15469638 (Pubitemid 40277057)
6. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Fayad R, Pini M, Sennello JA, et al. Gastroenterology 2007 132 601 614 10.1053/j.gastro.2006.11.026 17258715 (Pubitemid 46274660)
7. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Karmiris K, Koutroubakis IE, Xidakis C, et al. Inflamm Bowel Dis 2006 12 100 105 10.1097/01.MIB.0000200345.38837.46 16432373
8. Resistin is an inflammatory marker of inflammatory bowel disease in humans. Konrad A, Lehrke M, Schachinger V, et al. Eur J Gastroenterol Hepatol 2007 19 1070 1074 10.1097/MEG.0b013e3282f16251 17998831 (Pubitemid 350125378)
9. Intestinal, adipose, and liver inflammation in diet-induced obese mice. Li H, Lelliott C, Hakansson P, et al. Metabolism 2008 57 1704 1710 10.1016/j.metabol.2008.07.029 19013294
10. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Nishihara T, Matsuda M, Araki H, et al. Gastroenterology 2006 131 853 861 10.1053/j.gastro.2006.06.015 16952554 (Pubitemid 44307068)
11. Leptin: a pivotal mediator of intestinal inflammation in mice. Siegmund B, Lehr HA, Fantuzzi G, Gastroenterology 2002 122 2011 2025 10.1053/gast.2002. 33631 12055606 (Pubitemid 34651443)
12. Development of intestinal inflammation in double IL-10- and leptin-deficient mice. Siegmund B, Sennello JA, Lehr HA, et al. J Leukoc Biol 2004 76 782 786 10.1189/jlb.0404239 15240754 (Pubitemid 39313713)
13. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Valentini L, Wirth EK, Schweizer U, et al. Nutrition 2009 25 172 181 10.1016/j.nut.2008.07.020 18849144
14. Characterization of the impaired glucose homeostasis produced in C57BL/6 mice by chronic exposure to arsenic and high-fat diet. Paul DS, Walton FS, Saunders RJ, Styblo M, Environ Health Perspect 2011 119 1104 1109 10.1289/ehp.1003324 21592922
15. Adaptive immunity and adipose tissue biology. Kaminski DA, Randall TD, Trends Immunol 2010 31 384 390 10.1016/j.it.2010.08.001 20817556
16. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Salim SY, Soderholm JD, Inflamm Bowel Dis 2011 17 362 381 10.1002/ibd.21403 20725949
17. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Baumgart DC, Sandborn WJ, Lancet 2007 369 1641 1657 10.1016/S0140-6736(07)60751-X 17499606 (Pubitemid 46722637)
18. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. de La Serre CB, Ellis CL, Lee J, et al. Am J Physiol Gastrointest Liver Physiol 2010 299 440 448 10.1152/ajpgi.00098.2010 20508158
19. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Suzuki T, Hara H, Nutr Metab (Lond) 2010 7 19 10.1186/1743-7075-7-19
20. Nutrient-induced inflammation in the intestine. Ji Y, Sakata Y, Tso P, Curr Opin Clin Nutr Metab Care 2011 14 315 321 10.1097/MCO.0b013e3283476e74 21587069
21. LPS/TLR4 signal transduction pathway. Lu YC, Yeh WC, Ohashi PS, Cytokine 2008 42 145 151 10.1016/j.cyto.2008.01.006 18304834
22. Innate immunity and adipose tissue biology. Schaffler A, Scholmerich J, Trends Immunol 2010 31 228 235 10.1016/j.it.2010.03.001 20434953
23. Immunopathogenesis of inflammatory bowel disease. Shih DQ, Targan SR, World J Gastroenterol 2008 14 390 400 10.3748/wjg.14.390 18200661 (Pubitemid 351320847)
24. Immune dysfunction in inflammatory bowel disease. Neuman MG, Transl Res 2007 149 173 186 10.1016/j.trsl.2006.11.009 17383591 (Pubitemid 46442010)
25. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Brun P, Castagliuolo I, Di Leo V, et al. Am J Physiol Gastrointest Liver Physiol 2007 292 518 525 17023554
26. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Cani PD, Bibiloni R, Knauf C, et al. Diabetes 2008 57 1470 1481 10.2337/db07-1403 18305141
27. T-lymphocyte responses to intestinally absorbed antigens can contribute to adipose tissue inflammation and glucose intolerance during high fat feeding. Wang Y, Li J, Tang L, et al. PLoS One 2010 5 13951 10.1371/journal.pone.0013951 21085605
28. Adipose tissue inflammation: novel insight into the role of macrophages and lymphocytes. Sell H, Eckel J, Curr Opin Clin Nutr Metab Care 2010 13 366 370 10.1097/MCO.0b013e32833aab7f 20473150
29. Dead adipocytes and metabolic dysfunction: recent progress. West M, Curr Opin Endocrinol Diabetes Obes 2009 16 178 182 10.1097/MED.0b013e3283292327 19306530
30. Leptin, adiponectin, resistin, and ghrelin - implications for inflammatory bowel disease. Karmiris K, Koutroubakis IE, Kouroumalis EA, Mol Nutr Food Res 2008 52 855 866 10.1002/mnfr.200700050 18383234
31. Shifts in diet from high fat to high carbohydrate improved levels of adipokines and pro-inflammatory cytokines in mice fed a high-fat diet. Lee IS, Shin G, Choue R, Endocr J 2010 57 39 50 10.1507/endocrj.K09E-046 19822999
32. A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression. Barnea M, Shamay A, Stark AH, Madar Z, Obesity (Silver Spring) 2006 14 2145 2153 10.1038/oby.2006.251 (Pubitemid 46121969)
33. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Weigert J, Obermeier F, Neumeier M, et al. Inflamm Bowel Dis 2010 16 630 637 19714754
34. Omega-3 fatty acids exacerbate DSS-induced colitis through decreased adiponectin in colonic subepithelial myofibroblasts. Matsunaga H, Hokari R, Kurihara C, et al. Inflamm Bowel Dis 2008 14 1348 1357 10.1002/ibd.20491 18484673
35. Adiponectin and inflammation: consensus and controversy. Fantuzzi G, J Allergy Clin Immunol 2008 121 326 330 10.1016/j.jaci.2007.10.018 18061654
36. Immunomodulatory actions of leptin. Juge-Aubry CE, Meier CA, Mol Cell Endocrinol 2002 194 1 7 10.1016/S0303-7207(02)00191-0 12242022 (Pubitemid 35291914)
37. Leptin in the regulation of immunity, inflammation, and hematopoiesis. Fantuzzi G, Faggioni R, J Leukoc Biol 2000 68 437 446 11037963
38. Adipose tissue: a regulator of inflammation. Juge-Aubry CE, Henrichot E, Meier CA, Best Pract Res Clin Endocrinol Metab 2005 19 547 566 10.1016/j.beem.2005.07.009 16311216 (Pubitemid 41823815)
39. Distribution of the long leptin receptor isoform in brush border, basolateral membrane, and cytoplasm of enterocytes. Barrenetxe J, Villaro AC, Guembe L, et al. Gut 2002 50 797 802 10.1136/gut.50.6.797 12010881 (Pubitemid 34539041)
40. Colonic leptin: source of a novel proinflammatory cytokine involved in IBD. Sitaraman S, Liu X, Charrier L, et al. FASEB J 2004 18 696 698 14977884
41. Leptin up-regulates pro-inflammatory cytokines in discrete cells within mouse colon. Padidar S, Farquharson AJ, Williams LM, et al. J Cell Physiol 2011 226 2123 2130 10.1002/jcp.22546 21520064
42. A Mouse Model of Metabolic Syndrome; Increase in Visceral Adipose Tissue Precedes the Development of Fatty Liver and Insulin Resistance in High-Fat Diet-Fed Male KK/Ta Mice. Akagiri S, Naito Y, Ichikawa H, et al. J Clin Biochem Nutr 2008 42 150 157 10.3164/jcbn.2008022 18385833 (Pubitemid 351912434)
43. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Okayasu I, Hatakeyama S, Yamada M, et al. Gastroenterology 1990 98 694 702 1688816 (Pubitemid 20069706)
44. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Fazio S, Babaev VR, Murray AB, et al. Proc Natl Acad Sci USA 1997 94 4647 4652 10.1073/pnas.94.9.4647 9114045 (Pubitemid 27194297)
45. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Matthews DR, Hosker JP, Rudenski AS, et al. Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825 (Pubitemid 15018832)
46. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Santos SH, Fernandes LR, Mario EG, et al. Diabetes 2008 57 340 347 18025412
47. Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia. Nowakowski GS, Hoyer JD, Shanafelt TD, et al. J Clin Oncol 2009 27 1844 1849 10.1200/JCO.2008.17.0795 19255329
48. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. Vieira EL, Leonel AJ, Sad AP, et al. J Nutr Biochem 2011
49. Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice. McCafferty DM, Sihota E, Muscara M, et al. Am J Physiol Gastrointest Liver Physiol 2000 279 90 99 10898750
50. Aging correlates with reduction in regulatory-type cytokines and T cells in the gut mucosa. Santiago AF, Alves AC, Oliveira RP, et al. Immunobiology 2011
51. Taylor PMTDB, Mills KHG, In vitro culture and T cell lines and clones 1987
52. Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. Heneghan HM, Miller N, McAnena OJ, O'Brien T, Kerin MJ, J Clin Endocrinol Metab 2011 96 846 850 10.1210/jc.2010-2701 21367929
53. Experimental food allergy leads to adipose tissue inflammation, systemic metabolic alterations and weight loss in mice. Dourado LP, Noviello MD, Alvarenga DM, et al. Cell Immunol 2011